Clinical trial
Thrombosis and Inflammation in Vessels Initiative (TIVI)
NCT06552767 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thrombosis and Inflammation in Vessels Initiative (TIVI)
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 22, 2024
- Completion date
- January 30, 2034
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.